A CIK cell in-vitro culture method is disclosed.
本发明公开了一种CIK细胞体外培养方法。
CIK cell is a kind of anti-vims cell and is an important immunocyte to kill the tumor cell directly.
淋巴细胞为主，CIK细胞是抗病毒、直接杀伤肿瘤细胞的主要免疫细胞。
The cell used in adoptive immunotherapy must have strong cytotoxic and proliferative ability, so CIK cell is thought of the new generation anti-tumor adoptive immunity treatment.
用于过继免疫治疗的活性细胞必须具有较强的细胞活性和增殖力，CIK细胞被认为是新一代抗肿瘤过继细胞免疫治疗的首选方案。
CONCLUSION: CIK cell transfusion after micro-invasive treatments may improve the immunologic function in HCC patients, and play an important role in reducing the recurrence rate of HCC.
结论：微创治疗后联合cik细胞免疫治疗可提高肝癌患者的免疫功能，对降低肝癌的复发率具有重要作用。
CONCLUSION: CIK cell transfusion after micro-invasive treatments may improve the immunologic function in HCC patients, and play an important role in reducing the recurrence rate of HCC.
结论：微创治疗后联合cik细胞免疫治疗可提高肝癌患者的免疫功能，对降低肝癌的复发率具有重要作用。
应用推荐